FCMI
BPMC
Foresite Capital Management III’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-249,598
| Closed | -$19.5M | – | 11 |
|
|
2020
Q2 | $19.5M | Buy |
249,598
+79,698
| +47% | +$6.22M | 17.31% | 2 |
|
|
2020
Q1 | $9.94M | Buy |
+169,900
| New | +$9.94M | 15.82% | 3 |
|
|
2019
Q4 | – | Sell |
-559,381
| Closed | -$41.1M | – | 11 |
|
|
2019
Q3 | $41.1M | Buy |
559,381
+91,699
| +20% | +$6.74M | 15.69% | 3 |
|
|
2019
Q2 | $44.1M | Hold |
467,682
| – | – | 14.47% | 2 |
|
|
2019
Q1 | $37.4M | Hold |
467,682
| – | – | 9.75% | 4 |
|
|
2018
Q4 | $25.2M | Buy |
467,682
+267,682
| +134% | +$14.4M | 8.28% | 4 |
|
|
2018
Q3 | $15.6M | Sell |
200,000
-50,000
| -20% | -$3.9M | 3.44% | 8 |
|
|
2018
Q2 | $15.9M | Sell |
250,000
-150,000
| -38% | -$9.52M | 3.42% | 9 |
|
|
2018
Q1 | $36.7M | Hold |
400,000
| – | – | 7.99% | 6 |
|
|
2017
Q4 | $30.2M | Sell |
400,000
-67,682
| -14% | -$5.1M | 8.46% | 4 |
|
|
2017
Q3 | $32.6M | Buy |
467,682
+7,682
| +2% | +$535K | 8.97% | 4 |
|
|
2017
Q2 | $23.3M | Buy |
460,000
+199,600
| +77% | +$10.1M | 7.61% | 4 |
|
|
2017
Q1 | $10.4M | Sell |
260,400
-39,600
| -13% | -$1.58M | 4% | 8 |
|
|
2016
Q4 | $8.42M | Buy |
+300,000
| New | +$8.42M | 3.66% | 8 |
|